Dewey Steadman
Stock Analyst
(n/a)
# 4,477
Out of 4,479 analysts
25
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
7 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANIP ANI Pharmaceuticals | Maintains: Buy | n/a | $62.64 | - | 5 | Nov 12, 2018 | |
| PCRX Pacira BioSciences | Maintains: Hold | n/a | $22.74 | - | 10 | Oct 2, 2018 | |
| AMRX Amneal Pharmaceuticals | Maintains: Hold | n/a | $6.54 | - | 1 | Aug 14, 2018 | |
| ACET Adicet Bio | Downgrades: Sell | n/a | $1.10 | - | 4 | Apr 19, 2018 | |
| LPCN Lipocine | Downgrades: Hold | n/a | $7.56 | - | 1 | Jan 11, 2018 | |
| SVRA Savara | Maintains: Buy | n/a | $4.30 | - | 2 | Oct 30, 2017 | |
| PRGO Perrigo Company | Maintains: Buy | n/a | $25.99 | - | 2 | Sep 13, 2017 |
ANI Pharmaceuticals
Nov 12, 2018
Maintains: Buy
Price Target: n/a
Current: $62.64
Upside: -
Pacira BioSciences
Oct 2, 2018
Maintains: Hold
Price Target: n/a
Current: $22.74
Upside: -
Amneal Pharmaceuticals
Aug 14, 2018
Maintains: Hold
Price Target: n/a
Current: $6.54
Upside: -
Adicet Bio
Apr 19, 2018
Downgrades: Sell
Price Target: n/a
Current: $1.10
Upside: -
Lipocine
Jan 11, 2018
Downgrades: Hold
Price Target: n/a
Current: $7.56
Upside: -
Savara
Oct 30, 2017
Maintains: Buy
Price Target: n/a
Current: $4.30
Upside: -
Perrigo Company
Sep 13, 2017
Maintains: Buy
Price Target: n/a
Current: $25.99
Upside: -